Cite
MLA Citation
O. Hansen et al.. “EP-1229: Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC).” Radiotherapy and oncology, vol. 123, n.d., pp. S663–. http://access.bl.uk/ark:/81055/vdc_100047554812.0x000006